4CPS-136 Analysis of the situation of pharmaceutical care for patients with immune-mediated inflammatory diseases before and after the COVID-19 pandemic

Background and ImportancePharmaceutical care in patients with immune-mediated inflammatory diseases is essential for the correct management of pharmacotherapy. However, the arrival of the severe acute respiratory syndrome coronavirus 2 has required the adaptation of consultations to preserve the hea...

Full description

Saved in:
Bibliographic Details
Published in:European journal of hospital pharmacy. Science and practice 2024-03, Vol.31 (Suppl 1), p.A117-A117
Main Authors: Palanques-Pastor, T, López Sánchez, P, Ibarra Barrueta, MO, Ramírez Herráiz, E, Casellas Gibert, M, Monte Boquet, E, Rudi Sola, N
Format: Article
Language:English
Subjects:
Biological products
Coronaviruses
COVID-19
Pharmacists
Section 4: Clinical pharmacy services
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and ImportancePharmaceutical care in patients with immune-mediated inflammatory diseases is essential for the correct management of pharmacotherapy. However, the arrival of the severe acute respiratory syndrome coronavirus 2 has required the adaptation of consultations to preserve the health of patients.Aim and ObjectivesTo describe, analyse and compare the situation of pharmaceutical care consultations for outpatients with immune-mediated inflammatory diseases of the Pharmacy Services of Spain at two different times.Material and MethodsLongitudinal, multicentre and unidisciplinary descriptive observational study, carried out by the Immune-mediated Inflammatory Diseases Working Group of the Spanish Society of Hospital Pharmacy through a virtual survey in 2019 and 2021. Variables were collected regarding coordination, resources, biosimilars, unmet needs and telepharmacy. Numerical results were presented in absolute value and percentage and free text responses were grouped by topic areas. To compare the results between the two collection times, the Chi-Square test was used with a significance level of p
ISSN:2047-9956
2047-9964
DOI:10.1136/ejhpharm-2024-eahp.240